LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

LLY

908.52

+0.64%↑

UNH

593.89

-0.49%↓

NVO

131.93

+0.67%↑

JNJ

166.62

+1.37%↑

ABBV

196.25

+1.59%↑

Inicio・Lista de Acciones・Abbott Laboratories

Abbott Laboratories

Cerrado

Sector Salud

116.38 2.21

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

113.86

Máximo

116.71

Métricas clave
By Trading Economics
Ingresos	77M 1.3B
Ventas	420M 10B
P/B Media del Sector	32.37 103.001
BPA	1.14
Margen de beneficio	12.543
Empleados	114,000
EBITDA	170M 2.6B

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+11.61 upside

Dividendos
By Dow Jones
Próximas Ganancias	16 oct 2024
Fecha Próximo Dividendo	13 nov 2024
Próxima Fecha de Ex Dividendo	10 oct 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	197B
Apertura anterior	114.17
Cierre anterior	116.38

Noticias sobre sentimiento de mercado

By Acuity

72%

28%

318 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

113.255 / 114.66 Soporte y Resistencia

Abbott Laboratories Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

29 jul 2024, 10:30 UTC

Principales Movimientos del Mercado

Abbott Laboratories Shares Tumble on $495 Million Infant Formula Verdict

29 jul 2024, 09:27 UTC

Principales Movimientos del Mercado

Reckitt Benckiser Shares Tumble on Abbott's Baby-Formula Litigation

18 jul 2024, 12:21 UTC

Ganancias

Abbott Labs Lifts FY24 Outlook After 2Q Sales Rise

29 jul 2024, 10:15 UTC

Principales Movimientos del Mercado

Abbott Laboratories Shares Tumble on $495 Mln Infant Formula Verdict

29 jul 2024, 08:50 UTC

Acciones populares

Stocks to Watch Monday: Coinbase, Abbott, McDonald's, Heineken -- WSJ

18 jul 2024, 19:04 UTC

Charlas de Mercado

Ganancias

Abbott CEO Warns of Health Crisis if Preterm Formula Pulled -- Market Talk

18 jul 2024, 11:43 UTC

Ganancias

Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised -- IBD

18 jul 2024, 11:34 UTC

Ganancias

Abbott Labs Sees 3Q Adj EPS $1.18-Adj EPS $1.22 >ABT

18 jul 2024, 11:34 UTC

Ganancias

Abbott Labs Sees 3Q EPS 85c-EPS 89c >ABT

18 jul 2024, 11:31 UTC

Ganancias

Abbott Labs Narrows FY24 Organic Sales Growth View, Ex-COVID-19 Testing-Related Sales, to 9.5% to 10% >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Labs Sees FY Adj EPS $4.61-Adj EPS $4.71 >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Labs Sees FY EPS $3.30-EPS $3.40 >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Labs 2Q Organic Sales Growth Up 7.4% >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Labs 2Q Sales $10.38B >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Labs 2Q Adj EPS $1.14 >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Labs 2Q Net $1.3B >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Labs 2Q EPS 74c >ABT

18 jul 2024, 11:30 UTC

Ganancias

Abbott Raises Full-Yr Guidance

14 jul 2024, 22:41 UTC

Ganancias

Stocks Poised for Higher Open -- Barrons.com

12 jul 2024, 23:29 UTC

Adquisiciones, fusiones, absorciones

BP Says Oil Demand Is Falling, While OPEC Says It's Rising. What Gives? -- Barrons.com

17 abr 2024, 13:54 UTC

Ganancias

Abbott Labs Stock Is Slipping After Earnings Beat. Here's Why. -- Barrons.com

17 abr 2024, 12:41 UTC

Principales Noticias

Ganancias

Abbott Labs Stock Is Slipping. Disappointing Guidance Trumps a Strong Quarter. -- Barrons.com

17 abr 2024, 11:52 UTC

Ganancias

Abbott Labs Jumps, Retreats On Q1 Beat, Shy Guidance -- IBD

17 abr 2024, 11:45 UTC

Ganancias

Abbott Labs First-Quarter Results Top Estimates Amid Strong Medical Device Sales -- MarketWatch

17 abr 2024, 11:32 UTC

Ganancias

Abbott Labs Narrows 2024 Organic Sales Growth Ex-Covid-19 View to 8.5%-10% >ABT

17 abr 2024, 11:30 UTC

Ganancias

Abbott Labs 1Q Organic Sales for Underlying Base Business Rose 10.8% >ABT

17 abr 2024, 11:30 UTC

Ganancias

Abbott Raises Midpoint of Full-Year Guidance Ranges >ABT

17 abr 2024, 11:30 UTC

Ganancias

Abbott Labs Sees FY Adj EPS $4.55-Adj EPS $4.70 >ABT

17 abr 2024, 11:30 UTC

Ganancias

Abbott Labs 1Q Adj EPS 98c >ABT

17 abr 2024, 11:30 UTC

Ganancias

Abbott Labs 1Q EPS 70c >ABT

Comparación entre iguales

Cambio de precio

Abbott Laboratories Esperado

Precio Objetivo

By TipRanks

11.61% repunte

Estimación a 12 meses

Media 127.08 USD 11.61%

Máximo 143 USD

Mínimo 107 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Abbott Laboratories Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

14 ratings

Comprar

Mantener

Vender

De acuerdo con 14 analistas que ofrecen calificaciones bursátiles a para Abbott Laboratories Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

113.255 / 114.66Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Sentimiento

By Acuity

318 / 365 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.